基本信息
views: 320
Career Trajectory
Bio
Prof. Dr. Loibl is Chief Executive Officer of the GBG Forschungs GmbH and Chair of the German Breast Group (study group).
Prof. Dr. Sibylle Loibl is head of the German Breast Group.
Prof. Dr. Loibl has gained international recognition for her research into neoadjuvant breast cancer therapy, breast cancer during pregnancy and breast cancer in young women. She was responsible for establishing the Translational Research Department within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international clinical trials. In 2014, she was appointed to the Executive Board of the Breast International Group (BIG) and also sits on several international steering committees, translational research committees and independent data monitoring committees.
Prof. Dr. Loibl gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centrum für Hämatologie und Onkologie Bethanien, Frankfurt.
Prof. Dr. Loibl is author of more than 350 original and peer review articles, and co-author of more than 500 scientific papers cited by Medline; she has also written numerous books and book contributions. She is an active member of many important national and international organisations, such as ASCO, ESMO, EORTC-TRAFO, ESGO, DKG and the AGO Kommission Mamma and S3 Letilinienkommission to develop the breast cancer guidelines.
Prof. Dr. Sibylle Loibl is head of the German Breast Group.
Prof. Dr. Loibl has gained international recognition for her research into neoadjuvant breast cancer therapy, breast cancer during pregnancy and breast cancer in young women. She was responsible for establishing the Translational Research Department within the German Breast Group and has headed numerous research projects. In addition, Prof. Dr. Loibl has been involved in conducting and managing a significant number of national and international clinical trials. In 2014, she was appointed to the Executive Board of the Breast International Group (BIG) and also sits on several international steering committees, translational research committees and independent data monitoring committees.
Prof. Dr. Loibl gained a doctorate at the Ruprecht Karl University of Heidelberg and trained as a consultant in gynaecology and obstetrics at the women’s clinics of the university hospitals in Heidelberg and Frankfurt am Main. She devotes most of her time to clinical research within the German Breast Group and clinical work at the Centrum für Hämatologie und Onkologie Bethanien, Frankfurt.
Prof. Dr. Loibl is author of more than 350 original and peer review articles, and co-author of more than 500 scientific papers cited by Medline; she has also written numerous books and book contributions. She is an active member of many important national and international organisations, such as ASCO, ESMO, EORTC-TRAFO, ESGO, DKG and the AGO Kommission Mamma and S3 Letilinienkommission to develop the breast cancer guidelines.
Research Interests
Papers共 698 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Toralf Reimer,Bernd Gerber,Thorsten Kuehn, Nikola Bangemann,Anke Kleine-Tebbe,Andrea Stefek, Ulrike Doerste,Carolin Hammerle,Oliver Hoffmann,Alexander Hein,Isabel Rubio,Florentia Peintinger,
Cancer Researchno. 9_Supplement (2024): PO5-18
Chowdhury Arif Jahangir,David B. Page,Glenn Broeckx, Claudia A. Gonzalez, Caoimbhe Burke, Clodagh Murphy,Jorge S. Reis-Filho,Amy Ly,Paul W. Harms,Rajarsi R. Gupta,Michael Vieth,Akira Hida,
JOURNAL OF PATHOLOGYno. 3 (2024): 271-288
Annals of surgical oncologyno. 2 (2024): 1012-1013
Sibylle Loibl, Yeon Park,Sara Tolaney,Ioanna Gioni,Simon Johnston, Teresa Klinowska,Ingrid A. Mayer, Raquel Nunes,Barbara Pistilli,Mary Stuart, Angela Quintana,Andrew Walding,
Cancer Researchno. 9_Supplement (2024): PO4-27
Daniel Stover, Dominik Hlauschek,Erica Mayer,W. Fraser Symmans,Mark Watson, Iros Barozzi,Martin Filipits,Karla Ballman,Meritxell Bellet- Ezquerra,Justin Balko,Gabor Rubovszky,Nicholas Zdenkowski,
Cancer Researchno. 9_Supplement (2024): GS03-07
Cancer Researchno. 9_Supplement (2024): PO4-19
Cancer Researchno. 9_Supplement (2024): PS17-04
Rita K. Schmutzler,Theresa Link,Eric Hahnen, Mattea Reinisch,Jan Hauke,Marianne Just, Michael Untch,Corinna Ernst,Oliver Stötzer,Peter A. Fasching,Mohamad Kayali,Pauline Wimberger,
Cancer Researchno. 9_Supplement (2024): PO1-02
BREAST (2024): 103701-103701
BREAST CARE (2024)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn